Skip to main content
. 2016 Nov 19;5:43–52. doi: 10.1016/j.dadm.2016.10.007

Table 2.

Cortical thickness of SCD patients with and without clinical progression

Cortical thickness (mm) SCD stable (n = 253) SCD progression to MCI/dementia (n = 49) SCD progression to MCI (n = 32) SCD progression to AD (n = 9) SCD progression to non-AD (n = 8)
Whole-brain 2.17 (0.31) 2.04 (0.37) 2.15 (0.30) 1.84 (0.27) 1.80 (0.48)
AD-signature 2.39 (0.34) 2.21 (0.39) 2.34 (0.35) 1.96 (0.31) 2.05 (0.41)
Angular gyrus 2.06 (0.35) 1.93 (0.37) 2.04 (0.34) 2.04 (0.36) 1.72 (0.37)
Precuneus 1.95 (0.36) 1.81 (0.39) 1.98 (0.35) 1.89 (0.30) 1.70 (0.39)
Supramarginal 2.22 (0.32) 2.10 (0.35) 2.19 (0.33) 1.83 (0.33) 1.93 (0.35)
Frontal superior 2.34 (0.37) 2.20 (0.40) 2.30 (0.37) 1.94 (0.36) 2.00 (0.40)
Parietal superior 1.80 (0.32) 1.71 (0.40) 1.85 (0.30) 1.71 (0.21) 1.60 (0.40)
Temporal pole 3.38 (0.60) 3.06 (0.65) 3.24 (0.59) 2.44 (0.59) 2.97 (0.65)
Temporal inferior 2.62 (0.32) 2.44 (0.35) 2.54 (0.30) 2.13 (0.36) 2.29 (0.35)
Medial temporal 2.85 (0.42) 2.56 (0.47) 2.69 (0.44) 2.16 (0.46) 2.44 (0.47)
Frontal inferior 2.34 (0.29) 2.21 (0.32) 2.28 (0.30) 1.98 (0.32) 2.07 (0.32)
Hippocampus 7.18 (0.91) 6.41 (0.92) 6.73 (0.97) 5.99 (0.92) 6.84 (0.85)

Abbreviations: AD, Alzheimer's disease; MCI, mild cognitive impairment; SCD, subjective cognitive decline.

NOTE. Data are presented as the mean (standard deviation). Analyses of variance were used to investigate cortical thickness between groups (SCD stable, MCI, AD, and non-AD) with Bonferroni post hoc tests.

Significantly different between SCD progression to MCI and SCD progression to non-AD.

P < .05 significantly different between SCD progression to MCI, AD, or non-AD compared with SCD stable.

In cubic millimeters estimated with FIRST (FMRIB software library v5).